Steven Dikman

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

The American Journal of Human Genetics · 2001 · 323 citations

Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy

Kidney International · 2002 · 281 citations